Target
Cytochrome P450 2D6
Ligand
BDBM50604674
Substrate
n/a
Meas. Tech.
ChEMBL_2249037 (CHEMBL5163247)
IC50
25000±n/a nM
Citation
 Huang, YSendzik, MZhang, JGao, ZSun, YWang, LGu, JZhao, KYu, ZZhang, LZhang, QBlanz, JChen, ZDubost, VFang, DFeng, LFu, XKiffe, MLi, LLuo, FLuo, XMi, YMistry, PPearson, DPiaia, AScheufler, CTerranova, RWeiss, AZeng, JZhang, HZhang, JZhao, MDillon, MPJeay, SQi, WMoggs, JPissot-Soldermann, CLi, EAtadja, PLingel, AOyang, C Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies. J Med Chem 65:5317-5333 (2022) [PubMed] 
Target
Name:
Cytochrome P450 2D6
Synonyms:
CP2D6_HUMAN | CYP2D6 | CYP2DL1 | CYPIID6 | Cytochrome P450 2D6 (CYP2D6) | Debrisoquine 4-hydroxylase | P450-DB1
Type:
Protein
Mol. Mass.:
55774.82
Organism:
Homo sapiens (Human)
Description:
P10635
Residue:
497
Sequence:
MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR
  
Inhibitor
Name:
BDBM50604674
Synonyms:
CHEMBL5186280
Type:
Small organic molecule
Emp. Form.:
C21H20FN5O
Mol. Mass.:
377.4148
SMILES:
COc1cccc(F)c1CNc1ccc(-c2ccc(C)nc2C)c2nncn12
Structure:
Search PDB for entries with ligand similarity: